ChristianaCare’s 1,039-bed flagship academic medical center includes Delaware’s only level 1 trauma center, the only one between Baltimore and Philadelphia. In 2026, ChristianaCare Hospitals were ranked No. 1 in Delaware by U.S. News & World Report, and Christiana Hospital earned an “A” hospital safety grade from The Leapfrog Group. Its medical ICU has maintained American Association of Critical-Care Nurses “Beacon” recognition since 2009 and is Delaware’s most highly awarded Beacon unit. The Center for Heart & Vascular Health earned the American College of Cardiology’s HeartCARE Center national distinction of excellence for a fifth consecutive year in 2024 and integrates five cardiovascular specialties in one location. Christiana Hospital is Delaware’s only comprehensive stroke center and has the state’s only epilepsy monitoring unit, with rapid EEG technology introduced in 2024 that can identify suspected seizures in minutes. Its Center for Women’s & Children’s Health is the state’s only high-risk delivering hospital, with one of the nation’s few neonatal ICUs offering couplet care, and was the state’s only hospital named among Newsweek’s 2026 America’s Best Maternity Hospitals. At the Helen F. Graham Cancer Center & Research Institute, clinical-trial participation is about seven times the national average. In 2025, the National Cancer Institute renewed a $16.3 million grant supporting the nation’s only collaboration between an NCI-designated basic cancer center and an NCI community oncology research program, giving the partnership its highest possible rating and advancing first-in-human oncology trials.
